Skip to main content
Top
Published in:

Open Access 23-04-2025 | Meningitis | Case Report

Recurrent lymphocytic meningitis and progressive dementia: manifestations of relapsing polychondritis: a case report

Authors: Vanessa Ocampo-Piraquive, David Aguirre-Valencia, Tatiana Delgado-Mora, Andrés Hormaza-Jaramillo

Published in: BMC Neurology | Issue 1/2025

Login to get access

Abstract

Background

Recurrent polychondritis is an immune-mediated systemic disease that affects cartilaginous and non-cartilaginous structures. Despite being rare, multiple neurological manifestations have been described, such as involvement of cranial nerves; headache; ataxia; seizures; confusional syndromes; meningitis; limbic encephalitis; cerebral infarcts; psychosis; and dementia. We present a case report of patient with atypical manifestation of recurrent polychondritis.

Case presentation

A 71-year-old man with history of three episodes of meningitis who was admitted due to headache, walking difficulties, disorientation, loss of sphincter control and prostration. These symptoms were attributed to recurrent lymphocytic meningitis and progressive dementia secondary to relapsing polychondritis with excellent response to treatment with glucocorticoids and methotrexate.

Conclusion

The accurate identification of atypical manifestations in relapsing polychondritis is essential for the timely implementation of appropriate therapeutic interventions, thereby enhancing the overall quality of life for individuals affected by this pathology.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Recurrent lymphocytic meningitis and progressive dementia: manifestations of relapsing polychondritis: a case report
Authors
Vanessa Ocampo-Piraquive
David Aguirre-Valencia
Tatiana Delgado-Mora
Andrés Hormaza-Jaramillo
Publication date
23-04-2025
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2025
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03657-5

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest